Top compounds associated with response to CTC-479C5.6


Feature Type Standardized
Nominal ANOVA
mRNA semagacestat CTRPv2 pan-cancer AAC -0.028 0.4
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC -0.029 0.4
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.4
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.026 0.4
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.031 0.4
mRNA ML239 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA myricetin CTRPv2 pan-cancer AAC -0.028 0.4
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA betulinic acid CTRPv2 pan-cancer AAC -0.029 0.4
Download CSV